MICHAEL CHEN: Open Payments
NPI 1033612015 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 4 payments from 4 companies in 2025. Trend: 2023 $122 · 2024 $0 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 1 | $130 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| Ethicon US, LLC | 1 | $33 |
Products named: Qelbree, INGREZZA, UZEDY, Enseal.
Industry payments across TX — which companies pay providers there.
